SK10772000A3 - Monoklonálna protilátka anti alfa v-integrín, jej fragment, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie - Google Patents

Monoklonálna protilátka anti alfa v-integrín, jej fragment, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie Download PDF

Info

Publication number
SK10772000A3
SK10772000A3 SK1077-2000A SK10772000A SK10772000A3 SK 10772000 A3 SK10772000 A3 SK 10772000A3 SK 10772000 A SK10772000 A SK 10772000A SK 10772000 A3 SK10772000 A3 SK 10772000A3
Authority
SK
Slovakia
Prior art keywords
monoclonal antibody
integrin
cell
cell line
integrins
Prior art date
Application number
SK1077-2000A
Other languages
English (en)
Slovak (sk)
Inventor
Simon Goodman
Beate Diefenbach
Francesc Mitjans
Ana Carceller
Elisabet Rosell-Vives
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK10772000A3 publication Critical patent/SK10772000A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2839—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily
    • C07K16/2848—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the integrin superfamily against integrin beta3-subunit-containing molecules, e.g. CD41, CD51, CD61
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SK1077-2000A 1998-01-23 1999-01-11 Monoklonálna protilátka anti alfa v-integrín, jej fragment, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie SK10772000A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98101108 1998-01-23
PCT/EP1999/000101 WO1999037683A1 (de) 1998-01-23 1999-01-11 ADHESION RECEPTOR BLOCKER FOR αV-INTEGRINS

Publications (1)

Publication Number Publication Date
SK10772000A3 true SK10772000A3 (sk) 2001-01-18

Family

ID=8231295

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1077-2000A SK10772000A3 (sk) 1998-01-23 1999-01-11 Monoklonálna protilátka anti alfa v-integrín, jej fragment, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie

Country Status (17)

Country Link
EP (1) EP1049718B1 (de)
JP (1) JP2002501086A (de)
KR (1) KR20010034327A (de)
CN (1) CN1168741C (de)
AR (1) AR014464A1 (de)
AT (1) ATE322508T1 (de)
AU (1) AU2716399A (de)
BR (1) BR9907218A (de)
CA (1) CA2319160A1 (de)
DE (1) DE69930723T2 (de)
HU (1) HUP0101151A3 (de)
ID (1) ID27810A (de)
NO (1) NO20003767L (de)
PL (1) PL341569A1 (de)
SK (1) SK10772000A3 (de)
WO (1) WO1999037683A1 (de)
ZA (1) ZA99453B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1176195B1 (de) 1999-04-09 2013-05-22 Kyowa Hakko Kirin Co., Ltd. Verfahren zur kontrolle der aktivität von immunologisch funktionellem molekül
US6946292B2 (en) 2000-10-06 2005-09-20 Kyowa Hakko Kogyo Co., Ltd. Cells producing antibody compositions with increased antibody dependent cytotoxic activity
EP1381384B1 (de) 2001-04-24 2011-05-25 Merck Patent GmbH KOMBINATIONSTHERAPIE MIT ANTIANGIOGENEN MITTELN UND TNFalpha
EP1414491A4 (de) 2001-07-09 2005-07-06 Elan Pharm Inc Verfahren zur hemmung der toxizität von amyloid
US7829087B2 (en) 2001-07-09 2010-11-09 Elan Pharmaceuticals, Inc. Methods of treating cognitive impairment
MXPA04008870A (es) 2002-03-13 2005-06-17 Biogen Idec Inc Anticuerpos anti-avb6.
CN102875681A (zh) * 2005-07-08 2013-01-16 拜奥根Idec马萨诸塞公司 抗-αvβ6抗体及其用途
EP1973569B1 (de) 2006-01-18 2013-05-22 Merck Patent GmbH Spezifische therapie mit integrin-liganden zur krebsbehandlung
AR060040A1 (es) 2006-03-21 2008-05-21 Genentech Inc Antagonistas de vefg y de alfa5 beta 1
CN101563105B (zh) 2006-07-10 2013-01-23 拜奥根Idec马萨诸塞公司 用于抑制smad4-缺陷癌症的组合物和方法
EP2064244B1 (de) 2006-08-03 2019-06-05 MedImmune Limited GEGEN alphaVbeta6 GERICHTETE ANTIKÖRPER UND IHRE VERWENDUNG
JP2010516645A (ja) 2007-01-18 2010-05-20 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング 癌を治療するためのインテグリンリガンドを用いる特異的療法および薬剤
TWI547503B (zh) 2007-09-26 2016-09-01 建南德克公司 抗α5β1抗體、編碼其之核酸、包含其之組合物及其製造及使用方法
JP5637855B2 (ja) 2007-11-08 2014-12-10 ザ ジェネラル ホスピタル コーポレイション 蛋白尿症の治療のための方法及び組成物
AU2010229479B2 (en) 2009-03-25 2013-03-28 Genentech, Inc. Novel anti-alpha5beta1 antibodies and uses thereof
US20120130146A1 (en) 2009-05-25 2012-05-24 Merck Patent Gmbh Continuous administration of cilengitide in cancer treatments
CN105315370A (zh) * 2010-02-18 2016-02-10 加利福尼亚大学董事会 整合素αVβ8中和抗体
US10035860B2 (en) 2013-03-15 2018-07-31 Biogen Ma Inc. Anti-alpha V beta 6 antibodies and uses thereof
WO2014144466A1 (en) 2013-03-15 2014-09-18 Biogen Idec Ma Inc. Anti-alpha v beta 6 antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0719859T3 (da) * 1994-12-20 2003-10-20 Merck Patent Gmbh Anti-alfa V-integrin monoklonalt antistof

Also Published As

Publication number Publication date
EP1049718B1 (de) 2006-04-05
HUP0101151A3 (en) 2004-06-28
WO1999037683A1 (de) 1999-07-29
DE69930723D1 (de) 2006-05-18
KR20010034327A (ko) 2001-04-25
EP1049718A1 (de) 2000-11-08
ZA99453B (en) 1999-07-21
ID27810A (id) 2001-04-26
CN1288469A (zh) 2001-03-21
AR014464A1 (es) 2001-02-28
HUP0101151A2 (hu) 2001-08-28
JP2002501086A (ja) 2002-01-15
NO20003767D0 (no) 2000-07-21
ATE322508T1 (de) 2006-04-15
BR9907218A (pt) 2000-10-24
CA2319160A1 (en) 1999-07-29
PL341569A1 (en) 2001-04-23
AU2716399A (en) 1999-08-09
NO20003767L (no) 2000-07-21
CN1168741C (zh) 2004-09-29
DE69930723T2 (de) 2006-11-16

Similar Documents

Publication Publication Date Title
SK10772000A3 (sk) Monoklonálna protilátka anti alfa v-integrín, jej fragment, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
KR100450368B1 (ko) 항-αV-인테그린 모노크로날 항체
CA2184493C (en) Methods and compositions useful for inhibition of angiogenesis
CA2073031C (en) Anti-cd4 antibody homologs useful in prophylaxis and treatment of aids, arc and hiv infection
ES2210225T5 (es) Inhibición de la adherencia de los linfocitos al endotelio vascular mediante una nueva interacción receptor de matriz extracelular-ligando
WO1996008513A1 (en) Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
HU217792B (hu) Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására
US6951645B2 (en) Monoclonal antibodies recognizing human platelet membrane glycoproteins and use thereof in anti-thrombotic therapy
CZ20002659A3 (cs) Monoklonální protilátka anti av-integrin a její použití k inhibicí vazby avbetaó-integrinu na fibronektin
HK1034522A (en) MONOCLONAL ANTIBODY ANTIαν-INTEGRIN AND ITS USE TO INHIBITανβ6-INTEGRIN ATTACHMENT TO FIBRONECTIN
PT644768E (pt) Metodos e composicoes para inibir a inflamacao mediada por celulas endoteliais e fibrinogenio
MXPA00007178A (en) MONOCLONAL ANTIBODY ANTI&agr;v-INTEGRIN AND ITS USE TO INHIBIT&agr;v&bgr;6-INTEGRIN ATTACHMENT TO FIBRONECTIN
HK1013960B (en) Methods and compositions useful for inhibition of angiogenesis